An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir

一种公正的 OMIC 方法来确定可卡因调节 HIV 储存库的机制

基本信息

  • 批准号:
    10321500
  • 负责人:
  • 金额:
    $ 74.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-12-23 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT Substance abuse is associated with a more severe course of HIV disease as shown by the poor immune reconstitution in cART treated subjects and an increased rate of co-morbidities. The mechanisms that are involved in these poor clinical outcomes are not well understood most likely a consequence of poorly- controlled confounding factors in study cohorts, lack of quantitative assessment of drug levels,, incomplete measurement of immune function and poor understanding of the mechanisms that lead to HIV persistence. We have used systems biology a n d shown that t h e balance between pro and anti- inflammatory pathways a s major drivers of HIV persistence. Disruption of this balance leads to poor immune reconstitution in HIV infected cART treated subjects and to increased frequencies of latently infected cells. Cocaine use as shown by our preliminary results accounts for further perturbations of the balance between pro and anti inflammatory effector molecules and cells which results in lower levels of immune reconstitution in these subjects and perturbations in T cell homeostasis which have led to heightened HIV persistence in other cohorts. We have assembled a multidisciplinary group that will allow us to overcome these aforementioned hurdles and will use unbiased OMICs approaches to address our major objective which is to delineate the molecular mechanisms triggered by cocaine that lead to HIV persistence. In specific aim 1 we will use three independent state of the art assays to quantity the size and cellular localization of the HIV reservoir; we will use transcriptomics on specific cell subsets and other high density readouts including flow cytometry and system serology to identify the effector cells and molecules that are associated to increased HIV reservoir size. In specific aim 2 we will apply a global and targeted proteomics approach to validate molecular pathways triggered by cocaine that lead increased HIV persistence. Metabolomics will be used to identify the role of metabolites and particularly short chain fatty acids and cholesterol on HIV persistence. In Specific Aim 3 we will validate the mechanisms identified by gene expression and proteomics which we have shown in aims 1 and 2 to be associated to the impact of cocaine on HIV persistence; we will use a novel primary cell assay of HIV latency which allows for the first time to measure latency reactivation in multiple T cells subsets. LARA will allow us to confirm in vitro that cocaine and its metabolites can mobilize the above identified pathways and monitor their impact on the establishment of HIV latency in different memory T cell subsets and on the response to Latency Reactivating Agents.
项目摘要 药物滥用与贫困人口更严重的艾滋病毒疾病有关 在手推车治疗的受试者中的免疫重建和合并症率提高。这 这些较差的临床结果涉及的机制最有可能是 研究队列中缺乏混杂因素的结果,缺乏定量评估 药物水平,对免疫功能的不完整测量以及对机制的不良理解 导致艾滋病毒的持久性。我们已经使用了系统生物学和 炎症途径是艾滋病毒持久性的主要驱动力。这种平衡的破坏导致贫穷 在艾滋病毒感染的手推车治疗的受试者中,免疫重建受试者和潜在的频率增加 感染细胞。可卡因的使用如我们的初步结果所示 Pro和抗炎性效应子分子和细胞之间的平衡,这导致较低水平 这些受试者的免疫重建和T细胞稳态的扰动,这导致了增强 艾滋病毒在其他人群中的持久性。我们组建了一个多学科小组,这将使我们能够克服 这些上述障碍,并将采用公正的OMIC方法来解决我们的主要目标 是描绘可卡因触发的分子机制,导致可卡因导致HIV持久性。在特定目标1中 我们将使用三种独立的艺术测定状态来数量艾滋病毒的大小和细胞定位量 水库;我们将在特定的单元集和其他高密度读数(包括流量)上使用转录组学 细胞仪和系统血清学识别与HIV增加有关的效应细胞和分子 储层尺寸。在特定目标2中,我们将采用全球和有针对性的蛋白质组学方法来验证 可卡因触发的分子途径增加了HIV的持久性。代谢组学将用于 确定代谢物,尤其是短链脂肪酸和胆固醇在HIV持久性中的作用。在 特定目的3我们将验证通过基因表达和蛋白质组学确定的机制 在目标1和2中显示的与可卡因对艾滋病毒持久性的影响有关;我们将使用小说 艾滋病毒潜伏期的主要细胞测定法,该测定首次测量多个t中的潜伏期重新激活 细胞子集。 Lara将使我们能够在体外确认可卡因及其代谢物可以动员上述 识别途径并监控其对不同记忆T细胞中HIV潜伏期的影响的影响 子集以及对潜伏期重新激活剂的响应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rafick Pierre Sekaly其他文献

Rafick Pierre Sekaly的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rafick Pierre Sekaly', 18)}}的其他基金

MultiOMICS mechanistic identification of predictors of HIV DNA decay, restoration of immune homeostasis and HIV specific immunity in PWH with cancer receiving Immune check point therapy
接受免疫检查点治疗的癌症患者中 HIV DNA 衰变、免疫稳态恢复和 HIV 特异性免疫的预测因子的多组学机制鉴定
  • 批准号:
    10731665
  • 财政年份:
    2023
  • 资助金额:
    $ 74.39万
  • 项目类别:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
在 cART 治疗的感染 SIV 的猕猴中利用 IL-10 恢复免疫力并根除 HIV
  • 批准号:
    10588314
  • 财政年份:
    2023
  • 资助金额:
    $ 74.39万
  • 项目类别:
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
多组学鉴定和验证免疫干预触发的机制,旨在减少复制能力储库的大小
  • 批准号:
    10731661
  • 财政年份:
    2023
  • 资助金额:
    $ 74.39万
  • 项目类别:
MOIR - Administrative Core
MOIR - 行政核心
  • 批准号:
    10731662
  • 财政年份:
    2023
  • 资助金额:
    $ 74.39万
  • 项目类别:
I2 Control= Modulating Innate Immunity to Achieve Control of HIV
I2 Control= 调节先天免疫以实现对 HIV 的控制
  • 批准号:
    10731664
  • 财政年份:
    2023
  • 资助金额:
    $ 74.39万
  • 项目类别:
Emory/Georgia TB Research Advancement Center (TRAC)
埃默里/佐治亚州结核病研究促进中心 (TRAC)
  • 批准号:
    10429404
  • 财政年份:
    2022
  • 资助金额:
    $ 74.39万
  • 项目类别:
Emory/Georgia TB Research Advancement Center (TRAC)
埃默里/佐治亚州结核病研究促进中心 (TRAC)
  • 批准号:
    10596182
  • 财政年份:
    2022
  • 资助金额:
    $ 74.39万
  • 项目类别:
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials
采用多层方法开发经过验证的检测方法,以预测四价登革热病毒减毒活疫苗在 II 期和 III 期临床试验中的功效
  • 批准号:
    10341373
  • 财政年份:
    2021
  • 资助金额:
    $ 74.39万
  • 项目类别:
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.
研究蠕虫感染对乙型肝炎疫苗接种过程中微生物群组成和先天免疫的影响。
  • 批准号:
    10163555
  • 财政年份:
    2020
  • 资助金额:
    $ 74.39万
  • 项目类别:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
癌症和自身免疫中 COVID-19 感染的免疫调节
  • 批准号:
    10222321
  • 财政年份:
    2020
  • 资助金额:
    $ 74.39万
  • 项目类别:

相似海外基金

Investigating the role of prion-mediated epigenetic regulation in yeast using an integrative approach of multi-omics
使用多组学综合方法研究酵母中朊病毒介导的表观遗传调控的作用
  • 批准号:
    2332782
  • 财政年份:
    2024
  • 资助金额:
    $ 74.39万
  • 项目类别:
    Standard Grant
"Circuit-omics": A Novel Approach to Investigate Neural Circuitry of Stress
“回路组学”:研究压力神经回路的新方法
  • 批准号:
    MR/X003957/1
  • 财政年份:
    2023
  • 资助金额:
    $ 74.39万
  • 项目类别:
    Research Grant
Multimodal omics approach to identify health to cardiometabolic disease transitions
多模式组学方法确定健康状况向心脏代谢疾病的转变
  • 批准号:
    10753664
  • 财政年份:
    2023
  • 资助金额:
    $ 74.39万
  • 项目类别:
Multi-omic signatures of gut dysbiosis and cardiovascular comorbidities associated with HIV infection
与 HIV 感染相关的肠道菌群失调和心血管合并症的多组学特征
  • 批准号:
    10762411
  • 财政年份:
    2023
  • 资助金额:
    $ 74.39万
  • 项目类别:
The Role of Sex Hormones in Stroke Risk: A Sex-Specific Integrative Omics Analysis in the NHLBI Trans-Omics for Precision Medicine Cohorts
性激素在中风风险中的作用:精准医学队列 NHLBI 跨组学中性别特异性综合组学分析
  • 批准号:
    10657840
  • 财政年份:
    2023
  • 资助金额:
    $ 74.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了